代表作 |
1. Si Y, Ji XY, Cao XL, Dai XM, Xu LY, Zhao HX, Guo XC, Yan H, Zhang HT, Zhu C, Zhou Q, Tang M, Xia ZP, Li L, Cong YS, Ye S, Liang TB, Feng XH, Zhao B*. Src inhibits the hippo tumor suppressor pathway through tyrosine phosphorylation of lats1.Cancer Research, 2017, 77(18): 4868–4880. (IF=12.701) 2. Si Y, Zhang HT, Peng P, Zhu C, Shen J, Xiong YL, Liu XW, Xiang YC, Li WJ, Ren YL, Wan F, Zhang L, Liu Y*. GPS2 suppresses gastric cancer by destabilizing EGFR. Cancer Science, 2021. (IF=6.7) 3. Xiang YC#, Peng P#, Liu XW, Jin X, Shen J, Zhang T, Zhang L, Wan F, Ren YL, Yu QQ, Zhao HZ, Si Y*, Liu Y*. Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells. Acta pharmacologica Sinica, 2021. (IF=6.149) 4. Si Y#, Wang J#, Liu XW#, Zhou T, Xiang YC, Zhang T, Wang XH, Feng TT, Xu L, Yu QQ, Zhao HZ, Liu Y*. Ethoxysanguinarine, a novel direct activator of AMPK, induces autophagy and exhibits therapeutic potential in breast cancer cells. Frontiers in Pharmacology, 2020, 10: e1503. (IF=5.81) 5. Liu PF#, Xiang YC#, Liu XW, Zhang T, Yang R, Chen S,Xu L, Yu QQ, Zhao HZ, Zhang L, Liu Y*, Si Y*. Cucurbitacin B induces the lysosomal degradation of EGFR and suppresses the CIP2A/PP2A/Akt signaling axis in gefitinib-resistant non smallcell lung cancer. Molecules, 2019, 24(3). (IF=4.411) |
